Ayano Shima
Kanazawa, 9208640, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181.
Journal: The journal of prevention of Alzheimer's disease
Published: May 19, 2026
Atrial fibrillation/atrial flutter and reduced volumes of the hippocampus, amygdala, and thalamus: evidence from a community-based MRI study.
Journal: Frontiers in aging neuroscience
Published: April 06, 2026
Gadolinium enhancement of the cauda equina in a case of familial ALS with p.S135G SOD1 mutation.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: March 05, 2026
Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data.
Journal: Alzheimer's research & therapy
Published: September 22, 2025
Housing damage and forgetfulness following the 2024 Noto Peninsula earthquake, Japan.
Journal: Journal of Alzheimer's disease : JAD
Published: April 23, 2025
Green tea consumption and cerebral white matter lesions in community-dwelling older adults without dementia.
Journal: NPJ science of food
Published: August 03, 2024
Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function.
Journal: npj aging
Published: October 18, 2023
Vacuoles related to tissue neuron-astrocyte ratio and infiltration of macrophages/monocytes contribute to hyperintense brain signals on diffusion-weighted magnetic resonance imaging in sporadic Creutzfeldt-Jakob disease.
Journal: Journal of the neurological sciences
Published: September 12, 2022
Treatment with Rituximab in the Acute Phase of Relapsing Remitting Multiple Sclerosis.
Journal: Internal medicine (Tokyo, Japan)
Published: August 30, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026